Chair, SVI Board
Ms Shanahan has a research background in finance in Australian and overseas economies and share markets. She is Chair of Challenger Listed Investments and a non-Executive Director of Clinuvel Pharmaceuticals Ltd; DMP Asset Management Ltd and Kimberley Foundation of Australia Ltd. She is a former Chairman of St. Vincent’s Health Ltd, former member of the Australian Stock Exchange, and former Executive Director of a stockbroking firm, a fund management company and an actuarial company.
Dr Susan M Alberti AC
Dr Alberti AC is co-founder and Managing Director of DANSU Group and associated companies. She has a strong commitment to fundraising and promotion of medical research, in particular, juvenile diabetes. Dr Alberti is Chair of the SVI Foundation, Chairman of the Victoria University Foundation and also Vice President of the Western Bulldogs Football Club and Co-Chair of the Western Bulldogs Forever Foundation.
Professor Richard Fox
Professor Fox was Director of Research at St Vincent’s Health from 2007-2013 and Director of the Department of Clinical Haematology and Oncology at The Royal Melbourne Hospital and the University of Melbourne from 1985-2006. Amongst many roles, Prof Fox has has also been the President of Cancer Council Victoria and Chair of the Cooperative Centre for Cancer Therapeutics.
Professor Shitij Kapur
Professor Shitij Kapur, is the Dean and Assistant Vice-Chancellor (Health), Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne. Shitij is a clinician-scientist with expertise in psychiatry, neuroscience and brain imaging. He trained as a Psychiatrist at the University of Pittsburgh, and undertook a PhD and Fellowship at the University of Toronto. He is a Diplomate of the American Board of Psychiatry and Neurology, similarly Board Certified in Canada and has a specialist medical license in the United Kingdom.
Mr Paul Holyoake
Mr Holyoake is currently Executive Chairman, Oakton Limited, an ASX listed, information technology services company. From June 1988 to June 2005, Mr Holyoake was Managing Director and Chief Executive Officer, Oakton Limited.
Ms Karen Inge
MS Inge is an accredited practising dietitian with over 30 years’ experience, specialising in the areas of sports dietetics and nutrition communication. Ms Inge is the founding member and Past President of Sports Dietitians Australia and founding Head of Nutrition at the Victorian Institute of Sport. She has been a Director of the Institute of Health and Fitness, Melbourne since 1989. She is a respected nutrition commentator for media and is heavily involved in community service and philanthropy.
Professor Thomas WH Kay
Professor Kay is Director of SVI. He holds a Professorial appointment within the Department of Medicine, St. Vincent’s Hospital and The University of Melbourne. He also holds the position of Honorary Endocrinologist at St. Vincent’s Hospital. Professor Kay’s research interests are in the area of autoimmunity, particularly of type 1 (juvenile) diabetes.
Mr John T Macfarlane
Mr Macfarlane is non-Executive Director of both public and private companies in Australia and New Zealand. He retired from his executive role as Chairman and CEO of Deutsche Bank Group, Australia & New Zealand in 2014. Prior to returning to Australia in 2007, he spent seven years as President and CEO of Deutsche Bank, Japan. An economist by training, Mr Macfarlane held senior positions with Bankers Trust in Sydney, New York and New Zealand until its acquisition by Deutsche Bank in 1999. At Deutsche Bank he served on the Global Markets Executive Committee, the Global Banking Executive Committee and the Global Regional Management Committee of Deutsche Bank; as well as Co-Chair of the Asia Pacific Deutsche Bank Executive Management Committee.
Mr Stephen Marks
Mr Marks is the Managing Director of Stephen G.Marks & Co. Pty. Ltd. He is a Fellow of the Institute of Chartered Accountants and a Fellow of The Institute of Company Directors in Australia. He was formerly Chairman of the Sothertons Chartered Accountants National Board and Managing Partner of the Melbourne office. He has recently retired as the Director of Probity Services for RSM Bird Cameron. He is a member of the Audit Committee of Orygen Youth Health and the Investment Advisory Committee of DMP Asset Management Ltd.
Ms Susan O'Neill
Susan O'Neill is the Chief Executive Officer of St Vincent’s Hospital Melbourne. Sue took the helm at St Vincent’s in 2016, after nearly two years in charge of Albury Wodonga Health, and five years as Executive Director of Nursing of Cabrini Health. Sue has a passion for organisational excellence and has spent many years applying lean thinking principles to health care. Her specific focus has been in the areas of strategy development and deployment, integrated operational planning, patient flow & practice redesign,leadership, coaching and talent development. Sue is currently studying an executive MBA, has qualifications in cancer nursing and holds a Master of Nursing Science as well as being a fellow of the University of Pennsylvania Wharton Business School.
Professor Patricia O'Rourke
Patricia O’Rourke is the Chief Executive Officer of SVHA’s Public Hospitals Division. Prior to this, Patricia was the CEO of St Vincent’s Hospital Melbourne for 5years. Patricia has more than 20 years’ experience in the health care industry, including nursing and senior management roles. Patricia’s other positions have included Chief of Clinical Operations and Chief Nursing Officer at St Vincent’s Hospital Melbourne, providing strategic and operational advice to the Hospital CEO and clinical leadership to the Executive. Through her leadership of St Vincent’s Hospital Melbourne and its partners, Patricia has been instrumental in the significant progress made towards establishing the Aikenhead Centre for Medical Discovery (ACMD), the first biomedical engineering research and education Centre in Australia. Patricia currently serves as a Director on the Boards of VESKI and the Garvan Institute of Medical Research, and holds key roles within many other Boards and Committees in NSW and Victoria. Patricia is a graduate of the Australian Institute of Company Directors and a member of the Harvard Business Club of Australia.
Dr Marcus Tierney
Marcus is a taxation Partner at PwC in Melbourne. He currently manages and advises a broad cross-section of listed and private companies within the pharmaceutical, biotechnology, infrastructure, manufacturing and ICT industries in respect of R&D taxation and government grants and incentives. Further, he also works closely with small and medium sized enterprises from a broad range of industries to identify Angel, VC and other funding opportunities. Marcus was previously a member of the board of the O'Brien Institute.
Mr Michael Wachtel
Michael Wachtel was appointed to the Future Fund by Federal Treasurer, Scott Morrison and Finance Minister, Mathias Cormann in April 2016. Michael Wachtel was the Chairman (Asia Pacific & Oceania) of Ernst & Young (EY) (2010-2015); a member of the EY Global Governance Council (2007-2015); Global Risk Committee (2013-2016) and Global Leader for Tax Quality & Risk (2013-2016). He joined EY at the time of the EY integration with Andersen in 2002. He has been an adviser to Australia’s leading multinationals and high net worth families for over 30 years; consistently listed over 2 decades as one of Australia’s leading tax advisers in global surveys during his early career. Michael co-authored the BCA White Paper “Removing Tax Barriers to International Growth” (2001); and was the first person to author books on Australia’s new International Tax Regime in the early 90’s. Michael is a Board Member of the Australian Centre for the Moving Image (ACMI); a mentor to NFP CEOS through Kilfinan; a Past President of the Australian Chapter of the International Fiscal Association; a past member of the Tax Advisory Board and visiting fellow in the Melbourne University Law Faculty.